These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A physician discusses the dental impact of oral bisphosphonates. Roudebush CP J Indiana Dent Assoc; 2006-2007 Winter; 85(4):4-5. PubMed ID: 17489111 [No Abstract] [Full Text] [Related]
6. Bisphosphonate-associated osteonecrosis of the jaw: conclusions based on an analysis of case series. Landesberg R; Wilson T; Grbic JT Dent Today; 2006 Aug; 25(8):52, 54-7. PubMed ID: 16925161 [TBL] [Abstract][Full Text] [Related]
7. Alveolar bone and the bisphosphonates. Cheng A; Daly CG; Logan RM; Stein B; Goss AN Aust Dent J; 2009 Sep; 54 Suppl 1():S51-61. PubMed ID: 19737268 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive review of bisphosphonate therapy: implications for the oral and maxillofacial surgery patient. Ruggiero SL; Carlson ER; Assael LA J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):1. PubMed ID: 19371808 [No Abstract] [Full Text] [Related]
9. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part I: biological concepts with a review of the literature. Lee CY; Suzuki JB Implant Dent; 2009 Dec; 18(6):492-500. PubMed ID: 20009603 [TBL] [Abstract][Full Text] [Related]
10. Warning: bisphosphonates and osteochemonecrosis of the jaws. Flint SR; Sharkey S; Galvin S J Ir Dent Assoc; 2006; 52(2):79-83. PubMed ID: 16989369 [TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate medications and your oral health. J Am Dent Assoc; 2006 Jul; 137(7):1048. PubMed ID: 16803833 [No Abstract] [Full Text] [Related]
12. Bisphosphonate associated osteonecrosis of the jaws and endodontic treatment: two case reports. Fugazzotto PA; Lightfoot S J Mass Dent Soc; 2006; 55(2):5. PubMed ID: 16937899 [No Abstract] [Full Text] [Related]
13. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws. Dodson TB J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814 [TBL] [Abstract][Full Text] [Related]
14. Osteonecrosis in the jaws of patients who are using oral biphosphonates to treat osteoporosis. Dello Russo NM; Jeffcoat MK; Marx RE; Fugazzotto P Int J Oral Maxillofac Implants; 2007; 22(1):146-53. PubMed ID: 17340909 [No Abstract] [Full Text] [Related]
16. Osteonecrosis and bisphosphonates in oral and maxillofacial surgery. Chaudhry AN; Ruggiero SL Oral Maxillofac Surg Clin North Am; 2007 May; 19(2):199-206, vi. PubMed ID: 18088878 [TBL] [Abstract][Full Text] [Related]
17. News on bisphosphonates: but will patterns of use change? Garg A Dent Implantol Update; 2010 Sep; 21(9):71-2. PubMed ID: 20863016 [No Abstract] [Full Text] [Related]
18. Bisphosphonate osteonecrosis of the jaws in cancer patients. Kyrgidis A; Andreadis C Breast; 2009 Oct; 18(5):335. PubMed ID: 19783147 [No Abstract] [Full Text] [Related]
19. Bisphosphonates--what the dentist needs to know: practical considerations. Fantasia JE J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):53-60. PubMed ID: 19371815 [No Abstract] [Full Text] [Related]
20. Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update. Jimenez-Soriano Y; Bagan JV Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E88-91. PubMed ID: 15995577 [No Abstract] [Full Text] [Related] [Next] [New Search]